Worth reading
44Recurring
0–100. This measures how worthwhile something is to read, not how good or bad the company is.Direction
Improvement
Direction inferred from the company’s description.Scale
50.9
Year-on-year change in operating profit (%)Wording
Conditional
How definitive the wording is.Results for this period
First quarter1 April 2026 to 30 June 2026ConsolidatedJapanese GAAPNet Sales2,645Millions of yenYear on year +3.6%Progress 22.0%
Operating profit103Millions of yenYear on year +50.9%Progress 16.9%
Ordinary income91Millions of yenYear on year +75.8%Progress 16.3%
Net income attributable to owners of the parent92Millions of yen
The width of the band at each stage is based on revenue. The narrower it becomes toward the bottom, the smaller the proportion of revenue that remains as profit. The dotted outline is the full-year forecast and the band inside it is the result for this period. The progress rate is the result divided by the forecast.
Net income per share¥19.31
Financial position at period-end
Total assets10,622Millions of yen
of which net assets 3,578 Millions of yenEquity ratio 32.2%vs. prior year-end -0.1pt
塗りつぶした部分が自己資本比率です。総資産のうち、返済のいらない自前の資金がどれだけかを表します。The thin vertical line indicates the level at the end of the previous fiscal year.
Segment revenue
Medical Business635,98324.0%+10.3%
Platform Business841,72031.8%+1.2%
Broadband business918,85834.7%+1.4%
SaaS and DX business250,5939.5%+4.9%
Segment profit
Medical Business-84,356+43,700.0%
Platform Business158,971+132.5%
Broadband business129,397-7.1%
SaaS and DX business25,763+15,603.0%
Outlook and shareholder returns
Full-year earnings forecast
Net Sales12,000 Millions of yen (YoY +11.1%)
Operating profit610 Millions of yen (YoY +34.3%)
Ordinary income560 Millions of yen (YoY +32.9%)
Profit attributable to owners of the parent350 Millions of yen (YoY +38.2%)
Annual Dividend Forecast¥31.5 → ¥32.7
Factors Behind Changes in Business Performance
Growth in the Medical Business, recovery in advertising rates and page views in Media Services, an increase in paying subscribers to 10-gigabit fiber-optic broadband and MVNO services, customer acquisition for “FanGrowth” and “Sharely,” and the SaaS and DX Business returning to profitability
Disclosure regarding the going concern assumption
No applicable matters.
Change in accounting policy
基準改正に伴う変更 Noそれ以外の変更 Yes見積りの変更 No修正再表示 No
Changes in the scope of consolidationNew 1 / Name of newly added company Open Cure㈱ / Excluded 1 / Excluded Company Name iXIT㈱
Material subsequent eventsNo applicable matters.
Impairment lossNo applicable matters.
Breakdown of extraordinary income (loss)No extraordinary income or extraordinary losses were recorded in the first quarter.
Depreciation and amortization¥72,300 thousand
Availability of Supplementary Financial Results MaterialsYes
Availability of Financial Results BriefingAvailable (for institutional investors and analysts)
Issued Shares at Period-End4,878,690
Treasury Shares at Period-End74,000
| Item | Details |
|---|---|
| Fiscal Period Classification | First quarter |
| Accounting standards | Japanese GAAP |
| Consolidated / non-consolidated | Consolidated |
| Period Covered | 1 April 2026 to 30 June 2026 |
| Net Sales | 2,645 Millions of yen (YoY +3.6%) |
| Operating profit | 103 Millions of yen (YoY +50.9%) |
| Ordinary income | 91 Millions of yen (YoY +75.8%) |
| Profit attributable to owners of the parent | 92 Millions of yen |
| Net income per share | ¥19.31 |
| Equity ratio | End of the current fiscal period 32.2 / End of previous period 32.3 |
| Total assets | 10,622 Millions of yen |
| Net assets | 3,578 Millions of yen |
| Full-year earnings forecast | Net Sales 12,000 Millions of yen (YoY +11.1%) / Operating profit 610 Millions of yen (YoY +34.3%) / Ordinary income 560 Millions of yen (YoY +32.9%) / Profit attributable to owners of the parent 350 Millions of yen (YoY +38.2%) |
| Annual Dividend Forecast | ¥31.5 → ¥32.7 |
| Segment revenue | Segment Medical Business / Net Sales ¥635,983 thousand / Year on year against the same period last year 10.3, Segment Platform Business / Net Sales ¥841,720 thousand / Year on year against the same period last year 1.2, Segment Broadband business / Net Sales ¥918,858 thousand / Year on year against the same period last year 1.4, Segment SaaS and DX business / Net Sales ¥250,593 thousand / Year on year against the same period last year 4.9 / Notes External customer revenue in the segment information table was ¥248,994 thousand, and total revenue including intersegment revenue was ¥250,593 thousand |
| Segment profit | Segment Medical Business / Segment profit ¥-84,356 thousand / Year on year against the same period last year Loss widened from a loss of ¥43,700 thousand in the year-earlier period, Segment Platform Business / Segment profit ¥158,971 thousand / Year on year against the same period last year 132.5, Segment Broadband business / Segment profit ¥129,397 thousand / Year on year against the same period last year -7.1, Segment SaaS and DX business / Segment profit ¥25,763 thousand / Year on year against the same period last year Returned to profitability from a loss of ¥15,603 thousand in the year-earlier period |
| Depreciation and amortization | ¥72,300 thousand |
| Impairment loss | No applicable matters. |
| Breakdown of extraordinary income (loss) | No extraordinary income or extraordinary losses were recorded in the first quarter. |
| Disclosure regarding the going concern assumption | No applicable matters. |
| Change in accounting policy | Changes due to revisions to standards No / Other changes Yes / Change in accounting estimate No / Restatement No |
| Changes in the scope of consolidation | New 1 / Name of newly added company Open Cure㈱ / Excluded 1 / Excluded Company Name iXIT㈱ |
| Material subsequent events | No applicable matters. |
| Availability of Supplementary Financial Results Materials | Yes |
| Availability of Financial Results Briefing | Available (for institutional investors and analysts) |
| Issued Shares at Period-End | 4,878,690 |
| Treasury Shares at Period-End | 74,000 |
| Factors Behind Changes in Business Performance | Growth in the Medical Business, recovery in advertising rates and page views in Media Services, an increase in paying subscribers to 10-gigabit fiber-optic broadband and MVNO services, customer acquisition for “FanGrowth” and “Sharely,” and the SaaS and DX Business returning to profitability |
Items this document does not state (10)
Operating MarginCash flows from operating activitiesCash flows from investing activitiesCash flows from financing activitiesCash and cash equivalents at end of periodRevision to Earnings ForecastPayout ratioShareholder Return PolicyRegional salesOrders received and order backlog
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.Growth in the Medical Business contributed to revenue, while profitability improved in Media Services and the SaaS and DX Business returned to profitability.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.